Acutis Biosciences Unveils State of the Art Facility To Perform Integrated Biomarker and Data Analytics Services and Welcomes New Chief Commercial Officer for the Biopharma Market

Acutis Biosciences is pleased to announce the opening of its state-of-the-art 60,000-square-foot facility in Monmouth Junction, New Jersey. Acutis Biosciences combines a multi-omics biomarker profiling approach with unparalleled data integration, thereby providing pharmaceutical and biotechnology companies with the tools needed to advance clinical discovery. This unique approach builds on the expertise gained through its standard-of-care business, Acutis Diagnostics, which has processed over three million patient samples over the past seven years with turnaround times that have been consistently at the top of the industry.","Furthermore, the company has named Troy Tremaine as its Chief Commercial Officer